Gufic Biosciences Limited
NSE: GUFICBIO.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Pranav Jayesh Choksi
- Employees
- 1,491
- Headquarters
- Mumbai, India
- IPO year
- 2004
- Market cap
- ₹30.3B
- Website
- https://gufic.com
Loading GUFICBIO…
Loading profile data…Frequently asked questions about GUFICBIO
What does Gufic Biosciences Limited (GUFICBIO.NS) do?
Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, wh...
Where does GUFICBIO.NS trade?
Gufic Biosciences Limited (GUFICBIO.NS) trades on the National Stock Exchange of India.
What sector is GUFICBIO.NS in?
Gufic Biosciences Limited (GUFICBIO.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Gufic Biosciences Limited?
Pranav Jayesh Choksi is the chief executive officer of Gufic Biosciences Limited (GUFICBIO.NS).
Where is Gufic Biosciences Limited headquartered?
Gufic Biosciences Limited is headquartered in India.
Does GUFICBIO.NS pay a dividend?
Yes — Gufic Biosciences Limited (GUFICBIO.NS) paid a trailing twelve-month dividend of INR 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GUFICBIO.NS go public?
Gufic Biosciences Limited (GUFICBIO.NS) completed its initial public offering in 2004.